Aviva’s Amrize Ltd AMRZ Stock Holding History

Aviva’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Sell	289,488 -4,606	-2%	-$249K	0.02%	470
2026 Q1	$16.4M	Buy	294,094 +7,269	+3%	+$417K	0.03%	438
2025 Q4	$15.5M	Sell	286,825 -51,438	-15%	-$2.62M	0.03%	454
2025 Q3	$16.3M	Sell	338,263 -260,224	-43%	-$13.3M	0.03%	432
2025 Q2	$29.8M	Buy	+598,487	New	+$30.2M	0.06%	285

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aviva's AMRZ Position: Q2 2026 in Review

Aviva reduced its Amrize Ltd (AMRZ) stake by 1.6% in Q2 2026, selling an estimated $249K and leaving 289,488 shares worth $15.4M. The position accounts for 0.02% of the portfolio, ranked #470.

Aviva first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $29.8M in Q2 2025. 463 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

Aviva held 289,488 shares of Amrize Ltd worth $15.4M as of Q2 2026.
Aviva sold 4,606 Amrize Ltd shares in Q2 2026, an estimated $249K.
Amrize Ltd made up 0.02% of Aviva's portfolio in Q2 2026, its #470 holding.
Aviva first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
Aviva's Amrize Ltd position peaked at $29.8M in Q2 2025.
463 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.